145 related articles for article (PubMed ID: 10914736)
41. Autocrine transforming growth factor beta suppresses telomerase activity and transcription of human telomerase reverse transcriptase in human cancer cells.
Yang H; Kyo S; Takatura M; Sun L
Cell Growth Differ; 2001 Feb; 12(2):119-27. PubMed ID: 11243466
[TBL] [Abstract][Full Text] [Related]
42. The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters.
Majumdar AS; Hughes DE; Lichtsteiner SP; Wang Z; Lebkowski JS; Vasserot AP
Gene Ther; 2001 Apr; 8(7):568-78. PubMed ID: 11319624
[TBL] [Abstract][Full Text] [Related]
43. The role of HPV oncoproteins and cellular factors in maintenance of hTERT expression in cervical carcinoma cells.
Jeong Seo E; Jung Kim H; Jae Lee C; Tae Kang H; Seong Hwang E
Gynecol Oncol; 2004 Jul; 94(1):40-7. PubMed ID: 15262117
[TBL] [Abstract][Full Text] [Related]
44. Tumor-specific transgene expression from the human telomerase reverse transcriptase promoter enables targeting of the therapeutic effects of the Bax gene to cancers.
Gu J; Kagawa S; Takakura M; Kyo S; Inoue M; Roth JA; Fang B
Cancer Res; 2000 Oct; 60(19):5359-64. PubMed ID: 11034071
[TBL] [Abstract][Full Text] [Related]
45. Changes in telomerase activity, expression and splicing in response to differentiation of normal and carcinoma colon cells.
Fajkus J; Borsky M; Kunická Z; Kovaríková M; Dvoráková D; Hofmanová J; Kozubík A
Anticancer Res; 2003; 23(2B):1605-12. PubMed ID: 12820429
[TBL] [Abstract][Full Text] [Related]
46. Wild-type but not mutant androgen receptor inhibits expression of the hTERT telomerase subunit: a novel role of AR mutation for prostate cancer development.
Moehren U; Papaioannou M; Reeb CA; Grasselli A; Nanni S; Asim M; Roell D; Prade I; Farsetti A; Baniahmad A
FASEB J; 2008 Apr; 22(4):1258-67. PubMed ID: 17991730
[TBL] [Abstract][Full Text] [Related]
47. The 5'-end of hTERT mRNA is a good target for hammerhead ribozyme to suppress telomerase activity.
Yokoyama Y; Takahashi Y; Shinohara A; Wan X; Takahashi S; Niwa K; Tamaya T
Biochem Biophys Res Commun; 2000 Jun; 273(1):316-21. PubMed ID: 10873604
[TBL] [Abstract][Full Text] [Related]
48. Repression of human telomerase reverse transcriptase using artificial zinc finger transcription factors.
Sohn JH; Yeh BI; Choi JW; Yoon J; Namkung J; Park KK; Kim HW
Mol Cancer Res; 2010 Feb; 8(2):246-53. PubMed ID: 20145034
[TBL] [Abstract][Full Text] [Related]
49. Effect of c-MYC and E2F1 gene silencing and of 5-azacytidine treatment on telomerase activity in pancreatic cancer-derived cell lines.
Kumari A; Srinivasan R; Wig JD
Pancreatology; 2009; 9(4):360-8. PubMed ID: 19451745
[TBL] [Abstract][Full Text] [Related]
50. Molecular mechanisms of ceramide-mediated telomerase inhibition in the A549 human lung adenocarcinoma cell line.
Ogretmen B; Kraveka JM; Schady D; Usta J; Hannun YA; Obeid LM
J Biol Chem; 2001 Aug; 276(35):32506-14. PubMed ID: 11441001
[TBL] [Abstract][Full Text] [Related]
51. Indole-3-carbinol inhibits telomerase activity and gene expression in prostate cancer cell lines.
Adler S; Rashid G; Klein A
Anticancer Res; 2011 Nov; 31(11):3733-7. PubMed ID: 22110194
[TBL] [Abstract][Full Text] [Related]
52. Macrophage migration inhibitory factor is a direct target of HBP1-mediated transcriptional repression that is overexpressed in prostate cancer.
Chen YC; Zhang XW; Niu XH; Xin DQ; Zhao WP; Na YQ; Mao ZB
Oncogene; 2010 May; 29(21):3067-78. PubMed ID: 20383199
[TBL] [Abstract][Full Text] [Related]
53. MCPH1/BRIT1 represses transcription of the human telomerase reverse transcriptase gene.
Shi L; Li M; Su B
Gene; 2012 Mar; 495(1):1-9. PubMed ID: 22240313
[TBL] [Abstract][Full Text] [Related]
54. Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer.
Takakura M; Kyo S; Kanaya T; Tanaka M; Inoue M
Cancer Res; 1998 Apr; 58(7):1558-61. PubMed ID: 9537264
[TBL] [Abstract][Full Text] [Related]
55. Demethylation of the human telomerase catalytic subunit (hTERT) gene promoter reduced hTERT expression and telomerase activity and shortened telomeres.
Guilleret I; Benhattar J
Exp Cell Res; 2003 Oct; 289(2):326-34. PubMed ID: 14499633
[TBL] [Abstract][Full Text] [Related]
56. Telomerase activity is down regulated via decreases in hTERT mRNA but not TEP1 mRNA or hTERC during the differentiation of leukemic cells.
Koyanagi Y; Kobayashi D; Yajima T; Asanuma K; Kimura T; Sato T; Kida T; Yagihashi A; Kameshima H; Watanabe N
Anticancer Res; 2000; 20(2A):773-8. PubMed ID: 10810353
[TBL] [Abstract][Full Text] [Related]
57. In vivo regulation of hTERT expression and telomerase activity by androgen.
Guo C; Armbruster BN; Price DT; Counter CM
J Urol; 2003 Aug; 170(2 Pt 1):615-8. PubMed ID: 12853842
[TBL] [Abstract][Full Text] [Related]
58. Signaling through estrogen receptors modulates telomerase activity in human prostate cancer.
Nanni S; Narducci M; Della Pietra L; Moretti F; Grasselli A; De Carli P; Sacchi A; Pontecorvi A; Farsetti A
J Clin Invest; 2002 Jul; 110(2):219-27. PubMed ID: 12122114
[TBL] [Abstract][Full Text] [Related]
59. Identification and characterization of negative regulatory elements of the human telomerase catalytic subunit (hTERT) gene promoter: possible role of MZF-2 in transcriptional repression of hTERT.
Fujimoto K; Kyo S; Takakura M; Kanaya T; Kitagawa Y; Itoh H; Takahashi M; Inoue M
Nucleic Acids Res; 2000 Jul; 28(13):2557-62. PubMed ID: 10871406
[TBL] [Abstract][Full Text] [Related]
60. Role of telomerase in anticancer activity of pristimerin in prostate cancer cells.
Liu YB; Gao X; Deeb D; Pindolia K; Gautam SC
J Exp Ther Oncol; 2015; 11(1):41-9. PubMed ID: 26259389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
